KineMed: Press - Pathway-based Drug Discovery, Translational Medicine Development

Press Releases and General Interest Articles
	8/14/08	Dr. Robert Stein, MD, PhD, Named CEO of KineMed
	1/1/08	Repositioning Idle Drugs via Systematic Serendipity; Systems-based Approaches for Boosting Stalled Drugs
	10/11/07	KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
	8/28/07	KineMed to Collaborate with Merck KGaA to Validate New Applications for Drug Development Candidates; Technology to be Applied to Both Clinical- and Preclinical-Stage Compounds in Merck KGaA Pipeline
	8/14/07	KineMed Extends Alliance with CMIC in Japanese Market; Focus on In-Licensing Products in Metabolic Disease, Fibrosis and Reverse Cholesterol Transport
	8/7/2007	KineMed and Merck Enter Collaboration in Atherosclerosis
	8/3/2007	KineMed Completes $15 Million Offering of Convertible Notes; Funds Will Support Advancement of Lead Program into Clinical Testing in 2008
	5/21/2007	KineMed Evaluates the Mechanism of Action for Colesevelam in Patients With Type 2 Diabetes
	5/10/2007	KineMed Acquires Option to Exclusively License Patents Covering SR-B1 as a Target for Atherosclerotic Heart Disease from Massachusetts Institute of Technology.
	5/10/2007	KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time; Research Breakthrough Will Aid in Developing Therapies to Prevent and Reverse Atherosclerotic Heart Disease.
	3/1/2007	KineMed and Roche Enter Collaboration to Validate Translational KineMarker Technology in Fibrosis.
	2/2/2007	KineMed and Bayer Healthcare AG Enter Collaboration to Discover New Therapeutic Applications for Drug Candidates.
	11/16/2006	KineMed and Merck Enter Clinical-Stage Collaboration to Evaluate Therapeutic Target Pharmacodynamics.
	10/31/2006	KineMed to Present at Rodman & Renshaw 8th Annual Healthcare Conference.
	7/26/2006	KineMed Presents Innovative New Assays for Measurement of Neuroinflammation at Cold Spring Harbor Laboratory Meeting.
	6/29/2006	KineMed and Organon Enter Collaboration to Discover New Therapeutic Applications for Multiple Drug Candidates.
	5/25/2006	KineMed Enters Alliance with CMIC in Japanese Market.
	4/11/2006	KineMed Collaborates with Forbes Medi-Tech to Discover Non-Cardiovascular Indications for Development Stage Compound.
	4/3/2006	KineMed Announces Data from Program to Discover New Treatments for Neurodegenerative Diseases and Disorders of Mood and Cognition; Findings Presented at the Experimental Biology 2006 Meeting in San Francisco.
	4/3/2006	KineMed's Angiogenesis Program Offers New Approach to Cancer Drug Development; Results Presented at the Experimental Biology 2006 Meeting in San Francisco.
	3/21/2006	KineMed Presents Innovative New Assays for Measurement of in vivo Cartilage Dynamics at the 52nd Annual Meeting of the Orthopedic Research Society in Chicago, IL.
	12/13/2005	KineMed Presents Innovative New Assays for Measurement of in vivo Cartilage Dynamics at the World Congress on Osteoarthritis.
	12/09/2005	KineMed Presents Innovative New Assays for Measurement of in vivo Cartilage Dynamics at the World Congress on Osteoarthritis.
	11/16/2005	KineMed Presents Innovative Measurement of in vivo Neurogenesis at 35th Annual Meeting of the Society for Neuroscience.
	11/15/2005	KineMed Presents Innovative Measurement of Reverse Cholesterol Transport at the American Heart Association's (AHA) Scientific Sessions 2005 Conference
	11/10/2005	KineMed Announces Presentation at the American Heart Association's Scientific Sessions 2005 Conference
	6/15/2005	KineMed Presents Breakthroughs at American Diabetes Association Conference in Measuring Insulin Resistance and Pancreatic Beta Cell Regeneration
	5/03/2005	KineMed, Inc. Announces Presentation at the Targeting Metabolic Syndrome Conference in Cambridge, MA
	4/13/2005	KineMed Announces Partnership with Sosei Co. Ltd. for Repurposing Clinically Tested Compounds for New Indications
	3/17/2005	KineMed Announces Award of SBIR Phase I Grant for Program in Neurobiology
	3/01/2005	KineMed Reports Data Demonstrating New Insights into the Cellular Progression of Chronic Lymphocytic Leukemia (CLL)
	10/15/2004	BIO Investor Forum Web Cast. Click here to see KineMed's presentation.
	03/16/2004	FDA Position Paper; Challenge and Opportunity on the Critical Path to New Medical Products